Trieu Vuong 4
4 · Oncotelic Therapeutics, Inc. · Filed Jun 30, 2023
Insider Transaction Report
Form 4
Trieu Vuong
DirectorCHAIRMAN AND CEO10% Owner
Transactions
- Purchase
Common Stock
2023-06-29$0.02/sh+425,000$8,925→ 92,044,217 total - Purchase
Common Stock
2023-06-28$0.03/sh+75,000$1,950→ 91,619,217 total
Holdings
- 16,780,384(indirect: By Autotelic, Inc.)
Common Stock
- 6,872,529(indirect: By Spouse)
Common Stock